St. David's South Austin Medical Center

Austin, TX

Sorting 2 by

Accepting patients

DURGA-1

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Learn more
  • CAR T Cell
  • BCMA
  • CD19
  • Phase 1/2
  • Has results

Not yet accepting

DURGA-4

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Learn more
  • CAR T Cell
  • CD19
  • BCMA
  • Randomization
  • Phase 3